IRVINE, Calif., Sept. 8, 2026 /PRNewswire/ — PeproMene Bio, Inc. today announced the publication in The Lancet, one of the world’s leading medical journals, of results from its Phase 1 clinical trial evaluating PMB-CT01, the company’s first-in-class BAFF-R-targeted CAR T-cell therapy, in…
PARAMOUNT REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
LOS ANGELES and NEW YORK, May 4, 2026 /PRNewswire/ — Paramount Skydance Corporation (Nasdaq: …
Rugby-We’re not where we want to be yet, says Springboks coach Nienaber
South Africa in the news: Rugby-We’re not where we want to be yet, says Springboks coach …
Animal architecture: why we need to design buildings for wildlife as well as people
Animal architecture: why we need to design buildings for wildlife as well as people: How did early …